ClinicaliQ Trial Snapshot
- A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy — Recruiting • Phase IV • Respiratory / COPD / Asthma • NCT07761351.
- What is being tested: The ENCOMPASS study compares diagnostic accuracy and safety outcomes between CT-guided percutaneous lung biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT for obtaining tissue samples from small pulmonary nodules (≤2 cm).
- Patient eligibility overview: The trial includes patients requiring biopsy of pulmonary nodules 2 cm or smaller, representing a clinically challenging population where nodule accessibility and diagnostic yield are typically compromised compared to larger lesions.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The ENCOMPASS study is a post-market, multicenter, randomized controlled trial comparing two established approaches for obtaining a biopsy of small pulmonary nodules (≤2 cm): CT-guided percutaneous lung nodule biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT).
Eligibility Snapshot
- :
- Patient is aged 18 years or older at time of consent. 2. Diagnostic nodule biopsy(s) indicated per multidisciplinary team (or equivalent). 3. Target pulmonary nodule ≤2 cm in largest diameter.
- Patient is willing and able to give written informed consent for clinical study participation.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.